|
1
|
Mueller F, Fuchs B and Kaser-Hotz B:
Comparative biology of human and canine osteosarcoma. Anticancer
Res. 27:155–164. 2007.PubMed/NCBI
|
|
2
|
Withrow SJ, Powers BE, Straw RC and
Wilkins RM: Comparative aspects of osteosarcoma. Dog versus man.
Clin Orthop Relat Res. 270:159–168. 1991.PubMed/NCBI
|
|
3
|
Clark JC, Dass CR and Choong PF: A review
of clinical and molecular prognostic factors in osteosarcoma. J
Cancer Res Clin Oncol. 134:281–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bishop SC, Burlison JA and Blagg BS:
Hsp90: a novel target for the disruption of multiple signaling
cascades. Curr Cancer Drug Targets. 7:369–388. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuehlke A and Johnson JL: Hsp90 and
co-chaperones twist the functions of diverse client proteins.
Biopolymers. 93:211–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Solit DB and Chiosis G: Development and
application of Hsp90 inhibitors. Drug Discov Today. 13:38–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown MA, Zhu L, Schmidt C and Tucker PW:
Hsp90 - from signal transduction to cell transformation. Biochem
Biophys Res Commun. 363:241–246. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neckers L, Mimnaugh E and Schulte TW:
Hsp90 as an anti-cancer target. Drug Resist Updat. 2:165–172. 1999.
View Article : Google Scholar
|
|
10
|
Kamal A, Thao L, Sensintaffar J, et al: A
high-affinity conformation of Hsp90 confers tumor selectivity on
Hsp90 inhibitors. Nature. 425:407–410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hertlein E, Wagner AJ, Jones J, et al:
17-DMAG targets the nuclear factor-kappaB family of proteins to
induce apoptosis in chronic lymphocytic leukemia: clinical
implications of HSP90 inhibition. Blood. 116:45–53. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Porter JR, Fritz CC and Depew KM:
Discovery and development of Hsp90 inhibitors: a promising pathway
for cancer therapy. Curr Opin Chem Biol. 14:412–420. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amaravadi RK and Thompson CB: The roles of
therapy-induced autophagy and necrosis in cancer treatment. Clin
Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu C, Liu J, Hsu LC, Luo Y, Xiang R and
Chuang TH: Functional interaction of heat shock protein 90 and
Beclin 1 modulates Toll-like receptor-mediated autophagy. FASEB J.
25:2700–2710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palacios C, Martín-Pérez R, López-Pérez
AI, Pandiella A and López-Rivas A: Autophagy inhibition sensitizes
multiple myeloma cells to
17-dimethylaminoethylamino-17-demethoxy-geldanamycin-induced
apoptosis. Leuk Res. 34:1533–1538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roca H, Varsos Z and Pienta KJ: CCL2
protects prostate cancer PC3 cells from autophagic death via
phosphatidylinositol 3-kinase/AKT-dependent surviving
up-regulation. J Biol Chem. 283:25057–25073. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rami A and Kögel D: Apoptosis meets
autophagy-like cell death in the ischemic penumbra: two sides of
the same coin? Autophagy. 4:422–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanematsu S, Uehara N, Miki H, et al:
Autophagy inhibition enhances sulforaphane-induced apoptosis in
human breast cancer cells. Anticancer Res. 30:3381–3390.
2010.PubMed/NCBI
|
|
22
|
Ren Y, Huang F, Liu Y, Yang Y, Jiang Q and
Xu C: Autophagy inhibition through PI3K/Akt increases apoptosis by
sodium selenite in NB4 cells. BMB Rep. 42:599–604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petiot A, Ogier-Denis E, Blommaart EF,
Meijer AJ and Codogno P: Distinct classes of phosphatidylinositol
3′-kinases are involved in signaling pathways that control
macroautophagy in HT-29 cells. J Biol Chem. 275:992–998. 2000.
View Article : Google Scholar
|
|
24
|
Al Shaer L, Walsby E, Gilkes A, et al:
Heat shock protein 90 inhibition is cytotoxic to primary AML cells
expressing mutant FLT3 and results in altered downstream
signalling. Br J Haematol. 141:483–493. 2008.PubMed/NCBI
|
|
25
|
Lang SA, Moser C, Gaumann A, et al:
Targeting heat shock protein 90 in pancreatic cancer impairs
insulin-like growth factor-I receptor signaling, disrupts an
interleukin-6/signal-transducer and activator of transcription
3/hypoxia-inducible factor-1α autocrine loop, and reduces
orthotopic tumor growth. Clin Cancer Res. 13:6459–6468. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams CR, Tabios R, Linehan WM and
Neckers L: Intratumor injection of the Hsp90 inhibitor 17AAG
decreases tumor growth and induces apoptosis in a prostate cancer
xenograft model. J Urol. 178:1528–1532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yano M, Naito Z, Tanaka S and Asano G:
Expression and roles of heat shock proteins in human breast cancer.
Jpn J Cancer Res. 87:908–915. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meijer AJ and Codogno P: Regulation and
role of autophagy in mammalian cells. Int J Biochem Cell Biol.
36:2445–2462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu B, Cheng Y, Zhang B, Bian HJ and Bao
JK: Polygonatum cyrtonema lectin induces apoptosis and autophagy in
human melanoma A375 cells through a mitochondria-mediated
ROS-p38–p53 pathway. Cancer Lett. 275:54–60. 2009. View Article : Google Scholar
|
|
31
|
Wang Q, Chen Z, Diao X and Huang S:
Induction of autophagy-dependent apoptosis by the survivin
suppressant YM155 in prostate cancer cells. Cancer Lett. 302:29–36.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishikawa T, Tsuno NH, Okaji Y, et al:
Inhibition of autophagy potentiates sulforaphane-induced apoptosis
in human colon cancer cells. Ann Surg Oncol. 17:592–602. 2010.
View Article : Google Scholar : PubMed/NCBI
|
